[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Mckesson Corp (MCK)

Mckesson Corp (MCK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

McKesson Corp: How Much Longer Can Pharmaceutical Distribution Margins Defy Gravity?

McKesson Corporation (MCK) reports fiscal Q1 2027 earnings after market close on August 5, 2026, with analysts expecting $9.44 per share on the heels of four consecutive quarters of positive earnings surprises. The healthcare distribution giant faces a critical test as investors weigh whether its double-digit growth trajectory can continue amid evolving pharmaceutical distribution dynamics and margin pressures. With the stock trading at $830.43 and Wall Street maintaining an overwhelmingly bullish stance, the question is whether MCK can deliver another beat and sustain momentum that has driven shares up significantly over the past year.

McKesson Corporation is one of the largest pharmaceutical distributors in North...

Fundamentals

See More
  • Market Capitalization, $K 97,225,088
  • Shares Outstanding, K 117,078
  • Annual Sales, $ 403,430 M
  • Annual Income, $ 4,762 M
  • EBIT $ 6,212 M
  • EBITDA $ 6,941 M
  • 60-Month Beta 0.30
  • Price/Sales 0.24
  • Price/Cash Flow 18.79
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 37.00% (+1.00%)
  • Historical Volatility 32.35%
  • IV Percentile 99%
  • IV Rank 89.85%
  • IV High 39.00% on 05/06/26
  • IV Low 19.36% on 08/18/25
  • Expected Move (DTE 16) 47.26 (5.69%)
  • Put/Call Vol Ratio 0.51
  • Today's Volume 581
  • Volume Avg (30-Day) 541
  • Put/Call OI Ratio 0.50
  • Today's Open Interest 18,297
  • Open Int (30-Day) 17,763
  • Expected Range 783.17 to 877.69

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $9.44
  • Number of Estimates 5
  • High Estimate $9.65
  • Low Estimate $9.25
  • Prior Year $8.26
  • Growth Rate Est. (year over year) +14.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
776.00 +7.01%
on 07/06/26
907.00 -8.44%
on 07/29/26
+44.13 (+5.61%)
since 07/02/26
3-Month
723.68 +14.75%
on 05/11/26
907.00 -8.44%
on 07/29/26
+22.58 (+2.80%)
since 05/04/26
52-Week
637.00 +30.37%
on 08/12/25
999.00 -16.87%
on 03/03/26
+119.49 (+16.81%)
since 08/04/25

Most Recent Stories

More News
McKesson Corp: How Much Longer Can Pharmaceutical Distribution Margins Defy Gravity?

Barchart Research What to Expect from MCK Earnings MCK Generated August 4, 2026 Current Price $830.43 EPS Estimate $$9.44 Consensus Rating Strong Buy Average Move 6.25% McKesson Corp: How Much Longer Can...

MCK : 830.43 (+0.40%)
McKesson (MCK) Q2 Earnings: What To Expect

McKesson (MCK) Q2 Earnings: What To Expect

MCK : 830.43 (+0.40%)
3 Healthcare Stocks With Fresh Dividend Hikes and Different Income Profiles

McKesson, Encompass Health and Omega Healthcare Investors raised dividends, with payout ratios and yields showing varying levels of sustainability across the healthcare sector.

EHC : 110.50 (-1.75%)
MCK : 830.43 (+0.40%)
MarketBeat Week in Review – 07/27- 07/31

A weekly roundup covering Magnificent Seven earnings, Fed rate pauses, U.S.-Iran tensions, and MarketBeat analysts' takes on stocks including Microsoft, Alphabet, Broadcom, Tesla, and UnitedHealth.

CARR : 65.69 (+3.99%)
GOOGL : 377.65 (+1.11%)
AVGO : 418.16 (+6.61%)
SKHY : 154.38 (+8.17%)
MSFT : 492.81 (+1.06%)
SSNLF : 140.0000 (+114.69%)
TSLA : 327.35 (+1.64%)
COWZ.BZ : N/A (N/A)
KUBTY : 85.8000 (-0.46%)
WDC : 548.56 (+4.05%)
RTX : 217.93 (+0.59%)
AMD : 518.58 (+7.00%)
McKesson's Compounding Keeps Adding Up

McKesson posted strong fiscal 2026 results, raised guidance, boosted buybacks and its dividend, and maintains a Moderate Buy rating from analysts amid its evolving specialty business mix.

MCK : 830.43 (+0.40%)
COR : 306.28 (-0.68%)
CAH : 233.55 (-0.87%)
1 S&P 500 Stock on Our Buy List and 2 Facing Challenges

1 S&P 500 Stock on Our Buy List and 2 Facing Challenges

PCAR : 135.96 (+2.95%)
MCK : 830.43 (+0.40%)
LOW : 218.08 (+2.84%)
McKesson Corporation Raises Quarterly Dividend by 15% to $0.94 Per Share

The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of $0.94 per share of common stock, a 15% increase from $0.82 per share in the prior quarter. The dividend...

MCK : 830.43 (+0.40%)
McKesson's Q1 2027 Earnings: What to Expect

McKesson is expected to announce its second-quarter earnings next month, and Wall Street forecasts a double-digit rise in its profits.

XLV : 162.10 (-0.09%)
MCK : 830.43 (+0.40%)
$SPX : 7,736.52 (+1.79%)
2 Profitable Stocks Worth Investigating and 1 We Turn Down

2 Profitable Stocks Worth Investigating and 1 We Turn Down

MCK : 830.43 (+0.40%)
ACEL : 12.16 (+1.08%)
TILE : 34.61 (-1.00%)
McKesson (MCK) Stock Trades Down, Here Is Why

McKesson (MCK) Stock Trades Down, Here Is Why

MCK : 830.43 (+0.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

McKesson Corporation distributes pharmaceuticals, medical-surgical supplies and health and beauty care products principally in North America. The Company also develops, implements and supports software which facilitates the integration of data throughout the health enterprise. McKesson Corporation is...

See More

Key Turning Points

3rd Resistance Point 865.70
2nd Resistance Point 850.82
1st Resistance Point 840.63
Last Price 830.43
1st Support Level 815.56
2nd Support Level 800.68
3rd Support Level 790.49

See More

52-Week High 999.00
Fibonacci 61.8% 860.72
Last Price 830.43
Fibonacci 50% 818.00
Fibonacci 38.2% 775.28
52-Week Low 637.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.